These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 14585249)

  • 1. Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention.
    Lu TM; Ding YA; Lin SJ; Lee WS; Tai HC
    Eur Heart J; 2003 Nov; 24(21):1912-9. PubMed ID: 14585249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylated arginines in stable and acute patients with coronary artery disease before and after percutaneous revascularization.
    Frøbert O; Hjortshøj SP; Simonsen U; Ravkilde J
    Int J Cardiol; 2008 Sep; 129(2):288-91. PubMed ID: 17689741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated plasma asymmetric dimethylarginine level in acute myocardial infarction patients as a predictor of poor prognosis and angiographic impaired reperfusion.
    Sen N; Ozlu MF; Akgul EO; Kanat S; Cayci T; Turak O; Yaman H; Sokmen E; Ozcan F; Maden O; Demir AD; Covic A; Kanbay M
    Atherosclerosis; 2011 Nov; 219(1):304-10. PubMed ID: 21726864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma asymmetric dimethylarginine predicts death and major adverse cardiovascular events in individuals referred for coronary angiography.
    Lu TM; Chung MY; Lin MW; Hsu CP; Lin SJ
    Int J Cardiol; 2011 Dec; 153(2):135-40. PubMed ID: 21794936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
    Lu TM; Ding YA; Charng MJ; Lin SJ
    Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in der Region Augsburg study and experimental data.
    Maas R; Schulze F; Baumert J; Löwel H; Hamraz K; Schwedhelm E; Koenig W; Böger RH
    Clin Chem; 2007 Apr; 53(4):693-701. PubMed ID: 17317881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric dimethylarginine predicts major adverse cardiovascular events in patients with advanced peripheral artery disease.
    Mittermayer F; Krzyzanowska K; Exner M; Mlekusch W; Amighi J; Sabeti S; Minar E; Müller M; Wolzt M; Schillinger M
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2536-40. PubMed ID: 16931791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of baseline plasma ADMA levels to cardiovascular outcomes at 2 years in men with acute coronary syndrome referred for coronary angiography.
    Cavusoglu E; Ruwende C; Chopra V; Yanamadala S; Eng C; Pinsky DJ; Marmur JD
    Coron Artery Dis; 2009 Mar; 20(2):112-7. PubMed ID: 19240644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
    Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
    Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stent placement in patients with coronary heart disease decreases plasma levels of the endogenous nitric oxide synthase inhibitor ADMA.
    Ajtay Z; Scalera F; Cziráki A; Horváth I; Papp L; Sulyok E; Szabo C; Martens-Lobenhoffer J; Awiszus F; Bode-Böger SM
    Int J Mol Med; 2009 May; 23(5):651-7. PubMed ID: 19360324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of asymmetric dimethylarginine in patients with cardiac syndrome X.
    Lu TM; Lee TS; Lin SJ; Chan WL; Hsu CP
    PLoS One; 2017; 12(12):e0188995. PubMed ID: 29206850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic values of C-reactive protein levels on clinical outcome after implantation of sirolimus-eluting stents in patients on hemodialysis.
    Ishii H; Toriyama T; Aoyama T; Takahashi H; Amano T; Hayashi M; Tanaka M; Kawamura Y; Yasuda Y; Yuzawa Y; Maruyama S; Matsuo S; Matsubara T; Murohara T
    Circ Cardiovasc Interv; 2009 Dec; 2(6):513-8. PubMed ID: 20031768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
    Grander W; Dichtl W; Prokop W; Roithinger FX; Moes N; Friedrich G; Weidinger F; Pachinger O
    Clin Cardiol; 2004 Apr; 27(4):211-6. PubMed ID: 15119695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Asymmetric dimethylarginine predicts cardiovascular events in patients with type 2 diabetes.
    Krzyzanowska K; Mittermayer F; Wolzt M; Schernthaner G
    Diabetes Care; 2007 Jul; 30(7):1834-9. PubMed ID: 17456842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevation of asymmetric dimethylarginine in patients with unstable angina and recurrent cardiovascular events.
    Krempl TK; Maas R; Sydow K; Meinertz T; Böger RH; Kähler J
    Eur Heart J; 2005 Sep; 26(18):1846-51. PubMed ID: 15860520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic effects of asymmetrical dimethyl-L-arginine accumulation and endothelial progenitor cell deficiency on renal function decline during a 2-year follow-up in stable angina.
    Surdacki A; Marewicz E; Wieczorek-Surdacka E; Rakowski T; Szastak G; Pryjma J; Dudek D; Dubiel JS
    Nephrol Dial Transplant; 2010 Aug; 25(8):2576-83. PubMed ID: 19729464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma asymmetric dimethylarginine concentrations in newly diagnosed patients with acute myocardial infarction or unstable angina pectoris during two weeks of medical treatment.
    Bae SW; Stühlinger MC; Yoo HS; Yu KH; Park HK; Choi BY; Lee YS; Pachinger O; Choi YH; Lee SH; Park JE
    Am J Cardiol; 2005 Mar; 95(6):729-33. PubMed ID: 15757598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks: potential mechanisms beyond nitric oxide synthase inhibition.
    Wang Z; Tang WH; Cho L; Brennan DM; Hazen SL
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1383-91. PubMed ID: 19542023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High residual platelet reactivity after clopidogrel: extent of coronary atherosclerosis and periprocedural myocardial infarction in patients with stable angina undergoing percutaneous coronary intervention.
    Mangiacapra F; De Bruyne B; Muller O; Trana C; Ntalianis A; Bartunek J; Heyndrickx G; Di Sciascio G; Wijns W; Barbato E
    JACC Cardiovasc Interv; 2010 Jan; 3(1):35-40. PubMed ID: 20129566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction.
    Zeller M; Korandji C; Guilland JC; Sicard P; Vergely C; Lorgis L; Beer JC; Duvillard L; Lagrost AC; Moreau D; Gambert P; Cottin Y; Rochette L
    Arterioscler Thromb Vasc Biol; 2008 May; 28(5):954-60. PubMed ID: 18276906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.